Condition: Metastatic Cancer · Advanced Cancer · Sponsor: Indiana University
This is a non-randomized observational trial designed to collect detailed clinical, social determinant, and genomic data from patients enrolled in molecular oncology tumor boards across four comprehensive cancer centers.
This description comes directly from the study's public registry record.
Maria McQuade, BA · (317) 278-5238 · mcquadem@iu.edu
Bryan P Schneider, MD · 317-948-3855 · bpschnei@iu.edu
Always discuss trial participation with your own doctor first.
| Indiana University Health Melvin and Bren Simon Comprehensive Cancer Center | Indianapolis, Indiana, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06081517